Rankings
▼
Calendar
TNDM Q3 2024 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena
TNDM
Tandem Diabetes Care, Inc.
$1B
Q3 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$363M
+95.7% YoY
Gross Profit
$125M
34.3% margin
Operating Income
-$26M
-7.2% margin
Net Income
-$23M
-6.4% margin
EPS (Diluted)
$-0.35
QoQ Revenue Growth
+63.7%
Cash Flow
Operating Cash Flow
$27M
Free Cash Flow
$22M
Stock-Based Comp.
$26M
Balance Sheet
Total Assets
$958M
Total Liabilities
$720M
Stockholders' Equity
$238M
Cash & Equivalents
$49M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$363M
$186M
+95.7%
Gross Profit
$125M
$90M
+38.9%
Operating Income
-$26M
-$32M
+17.3%
Net Income
-$23M
-$33M
+29.5%
Revenue Segments
Supplies and Other
$128M
53%
Pump
$115M
47%
Geographic Segments
UNITED STATES
$172M
70%
Non-US
$72M
30%
← FY 2024
All Quarters
Q4 2024 →